TAP - Toumpoulis Aneurysm Prognosis

(TAP is a medical device undergoing IVDR CE certification. Not for sale)

The first diagnostic and prognostic blood test, based in mRNA and RT-qPCR technology for the human aortic aneurysm, both thoracic and abdominal.

Instructions for Use

Please fill in the fields below, to get access to the instruction manual of TAP

    Aortic Aneurysm

    A silent killer

    The aneurysm can suddenly break and most of the time the patient dies due to massive internal bleeding.

    It is calculated that around 1% – 2% of the population has aortic aneurysm most of them are being undiagnosed.
    The disease does not have any early symptoms.